Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker.
Wang Y, Ramachandran V, Sui D, Xu K, Haydu LE, Fang S, McQuade JL, Fisher SB, Lucci A, Keung EZ, Wargo J, Gershenwald JE, Ross MI, Lee JE.
Wang Y, et al. Among authors: lee je.
J Invest Dermatol. 2022 Jul;142(7):2046-2049.e3. doi: 10.1016/j.jid.2021.12.012. Epub 2021 Dec 21.
J Invest Dermatol. 2022.
PMID: 34952092
Free PMC article.
No abstract available.